Healthcare Finance News December 20, 2021
OIG found gaps between the number of providers authorized to treat patients with medication and the number of those who need care.
While more than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder in 2020, fewer than 16% of those beneficiaries received medication to treat their condition, according to a new report from the Office of Inspector General. They accounted for fewer than one in 6 of all Medicare beneficiaries with opioid use disorder.
Each of these 167,734 beneficiaries received at least one of the three approved drugs to treat opioid use disorder: buprenorphine, methadone, and naltrexone. The Food and Drug Administration recommends that all three of these drugs be available to all patients because certain medications...
Today's Sponsors
Today's Sponsor